Advanced company searchLink opens in new window

DR. MAX PHARMA LIMITED

Company number 07454391

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Oct 2021 GAZ2 Final Gazette dissolved following liquidation
27 Jul 2021 LIQ13 Return of final meeting in a members' voluntary winding up
03 Aug 2020 LIQ03 Liquidators' statement of receipts and payments to 10 June 2020
05 Jul 2019 LIQ01 Declaration of solvency
05 Jul 2019 AD01 Registered office address changed from First Floor Roxburghe House 273-287 Regent Street London W1B 2HA to Jupiter House Warley Hill Business Park the Drive Brentwood Essex CM13 3BE on 5 July 2019
04 Jul 2019 600 Appointment of a voluntary liquidator
04 Jul 2019 RESOLUTIONS Resolutions
  • LRESSP ‐ Special resolution to wind up on 2019-06-11
03 Oct 2018 AA Accounts for a small company made up to 31 December 2017
27 Sep 2018 RP04CS01 Second filing of Confirmation Statement dated 03/08/2017
27 Sep 2018 RP04CS01 Second filing of Confirmation Statement dated 03/08/2016
11 Sep 2018 CS01 Confirmation statement made on 3 August 2018 with updates
11 Sep 2018 PSC08 Notification of a person with significant control statement
11 Sep 2018 PSC07 Cessation of Marek Dospiva as a person with significant control on 30 June 2016
11 Sep 2018 PSC07 Cessation of Jaroslav Hascak as a person with significant control on 30 June 2016
11 Sep 2018 CH01 Director's details changed for Mr Tomas Fecko on 2 August 2018
31 Aug 2017 AA Accounts for a small company made up to 31 December 2016
17 Aug 2017 CS01 Confirmation statement made on 3 August 2017 with updates
  • ANNOTATION Clarification a second filed CS01 (statement of capital change and shareholder information change) was registered on 27/09/2018
17 Aug 2017 PSC01 Notification of Jaroslav Hascak as a person with significant control on 6 April 2016
16 Aug 2017 PSC01 Notification of Marek Dospiva as a person with significant control on 6 April 2016
01 Jun 2017 SH01 Statement of capital following an allotment of shares on 22 March 2017
  • GBP 550,100
25 Oct 2016 CS01 Confirmation statement made on 3 August 2016 with updates
  • ANNOTATION Clarification a second filed CS01 (shareholder information change and information about people with significant control) was registered on 27/09/2018
11 Oct 2016 AA Full accounts made up to 31 December 2015
13 Oct 2015 AA Accounts for a small company made up to 31 December 2014
29 Sep 2015 TM01 Termination of appointment of Ivan Berkes as a director on 18 September 2015
03 Aug 2015 AR01 Annual return made up to 3 August 2015 with full list of shareholders
Statement of capital on 2015-08-03
  • GBP 100